 Connection
Barry Uretsky to Ventricular Dysfunction, Left
This is a "connection" page, showing publications Barry Uretsky has written about Ventricular Dysfunction, Left.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.093 |
|
|
|
-
Uretsky BF. Time for left main stenting in patients with LV dysfunction? Proceed with caution! Catheter Cardiovasc Interv. 2010 Mar 01; 75(4):594-5.
Score: 0.340
-
Uretsky BF, Thygesen K, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, Cleland JG. Predictors of mortality from pump failure and sudden cardiac death in patients with systolic heart failure and left ventricular dyssynchrony: results of the CARE-HF trial. J Card Fail. 2008 Oct; 14(8):670-5.
Score: 0.304
-
Siraj A, Pattanshetty DJ, Agarwal SK, Uretsky BF. Retrograde recanalization of a nonchronic total occlusion lesion. Catheter Cardiovasc Interv. 2018 12 01; 92(7):1293-1296.
Score: 0.154
-
Sachdeva R, Agrawal M, Flynn SE, Werner GS, Uretsky BF. The myocardium supplied by a chronic total occlusion is a persistently ischemic zone. Catheter Cardiovasc Interv. 2014 Jan 01; 83(1):9-16.
Score: 0.107
-
Aleti S, Uretsky BF, Sachdeva R. Utility of fractional flow reserve to determine treatment after recent large myocardial infarction with severe left ventricular dysfunction. Catheter Cardiovasc Interv. 2012 Nov 01; 80(5):830-4.
Score: 0.097
-
Adams KF, Gheorghiade M, Uretsky BF, Young JB, Ahmed S, Tomasko L, Packer M. Patients with mild heart failure worsen during withdrawal from digoxin therapy. J Am Coll Cardiol. 1997 Jul; 30(1):42-8.
Score: 0.035
-
Mateo R, Jethmalani S, Angus DC, Gorcsan J, Uretsky B, Fung J. Interferon-associated left ventricular dysfunction in a liver transplant recipient. Dig Dis Sci. 1996 Jul; 41(7):1500-3.
Score: 0.033
-
deFilippi C, Wasserman S, Rosanio S, Tiblier E, Sperger H, Tocchi M, Christenson R, Uretsky B, Smiley M, Gold J, Muniz H, Badalamenti J, Herzog C, Henrich W. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA. 2003 Jul 16; 290(3):353-9.
Score: 0.013
-
Califf RM, Adams KF, McKenna WJ, Gheorghiade M, Uretsky BF, McNulty SE, Darius H, Schulman K, Zannad F, Handberg-Thurmond E, Harrell FE, Wheeler W, Soler-Soler J, Swedberg K. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST). Am Heart J. 1997 Jul; 134(1):44-54.
Score: 0.009
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|